About

We are shaping the future of oncology for patients.

Products or Services

cabozantinib has 3 indications in:
* Advanced RCC: In combination with nivolumab to treat renal cell carcinoma (RCC) that has spread (advanced RCC), and you have not already had treatment for your advanced RCC
Alone to treat people with renal cell carcinoma (RCC) that has spread (advanced RCC)

* 2nd line HCC

* DTC: Adults and children 12 years of age and older who have a type of thyroid cancer called differentiated thyroid cancer (DTC) that has spread (locally advanced or metastatic), and has progressed after treatment with a VEGFR-targeted treatment, and your DTC can no longer be treated with radioactive iodine, or you are not able to receive radioactive iodine treatment.